The COVID-19 pandemic has caused more than 6 million deaths worldwide as of April 2022,
while model data suggest that the toll of the pandemic on mortality could be at least three …

Abstract Coronavirus Disease 2019 (COVID-19) has been linked to severe consequences
among hospitalized patients diagnosed with pulmonary hypertension (PH), as evidenced by …

Pulmonary arterial hypertension (PAH) is common in severe coronavirus disease 2019
(COVID-19) and worsens the prognosis. Sildenafil, a phosphodiesterase-5 inhibitor, is …

Abstract Coronavirus disease (COVID-19) and pulmonary hypertension (PH) are closely
correlated. However, the mechanism is still poorly understood. In this article, we analyzed …

Background: Coronavirus disease 2019 (COVID-19) has potential risks for both clinically
worsening pulmonary hypertension (PH) and increasing mortality. However, the data …

Methods A large-scale clinical dataset, including patient information, medical history, and
laboratory test results, was collected. Two hundred patients with COVID-19 and …

Cardiovascular pathology can complicate the course of COVID-19. The study aimed to
identify echocardiographic abnormalities and key prognostic factors influencing severe and …

Pulmonary hypertension (PH) often complicates perioperative course following pediatric
cardiac surgery, often presenting unique challenges to the attending cardiac …

To the Editor, People with pulmonary hypertension (PH) are more vulnerable to the SARS-
CoV-2 virus; for example, greater severity of COVID-19 symptoms and higher rates of …

BACKGROUND Pulmonary arterial hypertension (PAH) is a disease of the arterioles
resulting in an increased resistance in pulmonary circulation with associated high pressures …